iTech Medical, Inc (OTCPK:IMSU) announced a private placement of units or shares at a minimum price per of CAD 0.20 per share or unit for minimum gross proceeds of CAD 2,300,000 on April 18, 2013. The units will consist of common shares and warrants.

On July 3, 2013, the company announced that it has amended the terms of the transaction. The company will now issue minimum of 11,500,000 common shares at a minimum price of CAD 0.20 per share for minimum gross proceeds of CAD 2,300,000 and a maximum of 15,000,000 common shares at the same price for maximum gross proceeds of CAD 3,000,000 on a best effort basis transaction. Jones, Gable & Company Ltd. will act as placement agent to the company. The company will pay cash commission of 10% of the total gross proceeds and compensation options. Each compensation options to acquire such number of common shares which is equal to 10% of the aggregate number of common shares sold pursuant to the transaction. Each agent's option will entitle the agent to acquire one additional common share of the company at an exercise price of CAD 0.20 per share for a period of two years from the completion of the transaction.

On November 13, 2013, the company announced that the transaction will close concurrently with the reverse merger. The company will issue 15,000,000 units in the transaction. Each unit consists of one common share and one half of a common share purchase warrant. Each warrant entitles the holder to acquire one common share at CAD 0.30 per share for a period of two years from the date of closing.

On June 5, 2014, the company announced that it has amended the terms of the transaction. The company will now issue minimum of 12,750,000 units at CAD 0.20 per unit for minimum gross proceeds of CAD 2,550,000.